Intervention

Aspart

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions3

Lead sponsors shown4

Clinical trials

4 shown

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 DiabetesNCT05199714 · 2022-02-21

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via PumpNCT04409587 · 2018-04-12

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 DiabetesNCT03336528 · 2018-01-02

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 DiabetesNCT00505882 · 2007-07-01

Common conditions

Type 1 Diabetes2 Type 2 Diabetes1 Type1 Diabetes Mellitus1

Leading sponsors

Emory University1 McGill University Health Centre/Research Institute of the McGill University Health Centre1 Mountain Diabetes and Endocrine Center1 University of Texas Southwestern Medical Center1

Trial status mix

COMPLETED3

WITHDRAWN1

Phase mix

PHASE43

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.